Table 2.

Knowledge of healthcare professionals on ADR reporting

Category	Statements/questions	n	%
Types of ADRs to be reported	ADRs to herbal medicine, herbal supplement, and traditionally used herbal products	3480	79.74
	ADRs to newly FDA-approved drugs (prescription and nonprescription drugs)	4006	91.80
	ADRs to existing FDA-approved drugs (prescription and nonprescription drugs)	3865	88.57
	ADRs to vaccines	3956	90.65
	ADRs to antineoplastics	3692	84.60
	ADRs to FDA-unapproved drugs (prescription and nonprescription drugs)	3213	73.63
Knowledge on NPVC	Are you aware of the NPVC in the Philippines?	2020 (Yes)	46.29
	Are you aware of the roles, programs, and projects of the NPVC?	1553 (Yes)	35.59
Knowledge on ADR reporting in the workplace	Are there guidelines available in your workplace pertaining to ADR reporting?	3247 (Yes)	74.40
Available reporting options in the workplace	Paper-based reporting only	1355	41.73
	Online ADR reporting only	610	18.79
	Telephone call to the NPVC only	46	1.42
	Paper-based reporting and online ADR reporting system	642	19.77
	Paper-based reporting and telephone call to the NPVC	48	1.48
	Paper-based reporting, online ADR reporting, and telephone call to the NPVC	298	9.18
	Online ADR reporting and telephone call to the NPVC	88	2.71
	No idea	160	4.93
Sources of information for ADRs to newer drugs	Textbooks, journals (both printed and online)	2857	65.47
	FDA Philippines website and its related platform	3238	74.20
	Foreign regulatory agencies (e.g., US FDA, European Medicines Agency)	1450	33.23
	Internet (other than regulatory agencies website and their platforms)	2969	68.03
	Seminars/conferences	2639	60.47
	Drug advertisements, product catalog, and product inserts	2154	49.36
	VigiAccess™	316	7.24
	HCPs and medical representatives	2111	48.37

N = 4364